IFNA1 and hepatitis C virus infection: Historically, IFN-based therapies, i.e., standard IFN-α or pegylated (PEG)-IFN-α in combination with ribavirin (RBV), were the standard of care for hepatitis C for several years, as described in Supplementary File S1.